MEI Pharma (NASDAQ:MEIP) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Monday morning. The brokerage issued a hold rating on the stock. Several other equities analysts have also issued reports on MEIP. TheStreet raised MEI Pharma from a d- rating to a c- rating in a research note on […]
More Stories
Morgan Stanley Boosts Ulta Beauty (NASDAQ:ULTA) Price Target to $550.00
Ulta Beauty (NASDAQ:ULTA – Free Report) had its price target raised by Morgan Stanley from $460.00 to $550.00 in a...
Ulta Beauty (NASDAQ:ULTA) Price Target Raised to $525.00
Ulta Beauty (NASDAQ:ULTA – Free Report) had its price target increased by Robert W. Baird from $440.00 to $525.00 in...
UiPath (NYSE:PATH) Given New $15.00 Price Target at Evercore ISI
UiPath (NYSE:PATH – Free Report) had its price target lifted by Evercore ISI from $11.00 to $15.00 in a research...
California Water Service Group (NYSE:CWT) Shares Sold by Millennium Management LLC
Millennium Management LLC decreased its position in shares of California Water Service Group (NYSE:CWT – Free Report) by 55.1% during...
Promising Pharmaceutical Stocks To Follow Today – May 29th
Veeva Systems, Eli Lilly and Company, D-Wave Quantum, Honeywell International, Thermo Fisher Scientific, Alzamend Neuro, and JD.com are the seven...
SLM Co. (NASDAQ:SLM) Shares Acquired by ProShare Advisors LLC
ProShare Advisors LLC raised its position in SLM Co. (NASDAQ:SLM – Free Report) by 4.8% in the 4th quarter, Holdings...